- Is Alzheimers Drug Discovery Foundation a tax-exempt 501(c)(3)?
- Yes. Alzheimers Drug Discovery Foundation is recognised by the IRS as a 501(c)(3) organisation (EIN 20-1082179). The IRS recognised Alzheimers Drug Discovery Foundation as tax-exempt in September 2005.
- What is Alzheimers Drug Discovery Foundation's EIN?
- Alzheimers Drug Discovery Foundation's Employer Identification Number (EIN) is 20-1082179. The EIN was assigned by the IRS in September 2005. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Alzheimers Drug Discovery Foundation do?
- Accelerate the Discovery of drugs to prevent and treat Alzheimer's disease and related dementias.
- Where is Alzheimers Drug Discovery Foundation located?
- Alzheimers Drug Discovery Foundation is located at 57 West 57th St 904, New York, NY, 10019.
- When was Alzheimers Drug Discovery Foundation founded or recognised by the IRS?
- Alzheimers Drug Discovery Foundation was recognised by the IRS as a tax-exempt organisation in September 2005. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Alzheimers Drug Discovery Foundation's annual revenue?
- On its most recent Form 990 (fiscal year 2024), Alzheimers Drug Discovery Foundation reported $47.3M in total revenue and $88.3M in total expenses.
- Has Alzheimers Drug Discovery Foundation been auto-revoked by the IRS?
- No. Alzheimers Drug Discovery Foundation (EIN 20-1082179) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Alzheimers Drug Discovery Foundation listed in IRS Publication 78?
- Yes. Alzheimers Drug Discovery Foundation is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
